Page 30 - Read Online

Page 350 Seno et al. Cancer Drug Resist 2019;2:335-50 I http://dx.doi.org/10.20517/cdr.2019.01

36. Nagata S. Apoptotic DNA fragmentation. Exp Cell Res 2000;256:12-8.
37. Zhu J, Dou Z, Sammons MA, Levine AJ, Berger SL. Lysine methylation represses p53 activity in teratocarcinoma cancer cells. Proc
Natl Acad Sci U S A 2016;113:9822-7.
38. Lutzker SG, Levine AJ. A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular
differentiation. Nat Med 1996;2:804-10.
39. Wang YH, Scadden DT. Harnessing the apoptotic programs in cancer stem-like cells. EMBO Rep 2015;16:1084-98.
40. Zachara NE, Molina H, Wong KY, Pandey A, Hart GW. The dynamic stress-induced “O-GlcNAc-ome” highlights functions for
O-GlcNAc in regulating DNA damage/repair and other cellular pathways. Amino Acids 2011;40:793-808.
41. Miura Y, Sakurai Y, Endo T. O-GlcNAc modification affects the ATM-mediated DNA damage response. Biochim Biophys Acta
2012;1820:1678-85.
42. Johnson B, Opimba M, Bernier J. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells. Biochim
Biophys Acta 2014;1840:191-8.
43. Speakman CM, Domke TC, Wongpaiboonwattana W, Sanders K, Mudaliar M, et al. Elevated O-GlcNAc levels activate epigenetically
repressed genes and delay mouse ESC differentiation without affecting naïve to primed cell transition. Stem Cells 2014;32:2605-15.
44. Pang B, Qiao X, Janssen L, Velds A, Groothuis T, et al. Drug-induced histone eviction from open chromatin contributes to the
chemotherapeutic effects of doxorubicin. Nat Commun 2013;4:1908.
45. Arnoult D, Gaume B, Karbowski M, Sharpe JC, Cecconi F, et al. Mitochondrial release of AIF and EndoG requires caspase activation
downstream of Bax/Bak-mediated permeabilization. EMBO J 2003;22:4385-99.
46. Guo W, Zhang Y, Ling Z, Liu X, Zhao X, et al. Caspase-3 feedback loop enhances Bid-induced AIF/endoG and Bak activation in Bax
and p53-independent manner. Cell Death Dis 2015;6:e1919.
47. Calle AS, Nair N, Oo AK, Prieto-Vila M, Koga M, et al. A new PDAC mouse model originated from iPSCs-converted pancreatic cancer
stem cells (CSCcm). Am J Cancer Res 2016;6:2799-815.
48. Nair N, Calle AS, Zahra MH, Prieto-Vila M, Oo AKK, et al. A cancer stem cell model as the point of origin of cancer-associated
fibroblasts in tumor microenvironment. Sci Rep 2017;7:6838.